STOCKSCREENR

0HIY.L

LSE

Atara Biotherapeutics, Inc.

$4.99+0.39(+8.54%)Mkt Cap: $40.84M

Key Stats

Market Cap

$40.84M

P/E Ratio

-1.37

EPS

$-3.65

Dividend Yield

0.00%

52-Week Range

$0.20 — $4.99

Volume

78

Avg Volume

52.10K

Beta

-0.33

Price Alerts for 0HIY.L

Get alerted when 0HIY.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-1.37

Forward P/E

23.03

PEG Ratio

0.05

P/S (TTM)

0.36

P/B (TTM)

-1.72

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.79%

ROA (TTM)

1.62%

ROIC

—

Gross Margin

0.82%

Operating Margin

0.30%

Net Margin

—

Debt/Equity

-1.37

Current Ratio

0.82

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.35%

EPS Growth (5Y)

+0.29%

Sales Growth (3Y)

+5.10%

Sales Growth (5Y)

+3.06%

EPS Est (This Year)

$0.22

EPS Est (Next Year)

$0.14

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.68

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

7.21M

Float

4.23M

Free Float %

58.70%

Technicals

RSI (14)

60.22

SMA 20

$4.94

SMA 50

$11.60

SMA 200

$11.76

ATR (14)

0.38

Volatility (Week)

0.04%

Volatility (Month)

0.15%

Pattern

—

Performance

1 Day

+2.24%

1 Week

+0.00%

1 Month

-66.20%

3 Months

-55.85%

6 Months

-52.33%

1 Year

—

YTD

-71.99%

All-Time High

$19.05

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

LSE

IPO Date

2018-01-29

Employees

153

CEO

Anhco Nguyen

Index Membership

—

Website

https://www.atarabio.com

Atara Biotherapeutics, Inc. (0HIY.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $40.84M, a P/E ratio of -1.37, 0HIY.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0HIY.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SDEV

Stablecoin Development Corp.

$1.24

-2.36%

$33.02M

0DOL.L

Biofrontera AG

$2.50

+1.63%

$111.43M

MSLE

Satellos Bioscience Inc. Common Stock

$7.95

+9.35%

$10.24M

KYNB

Kyntra Bio, Inc.

$7.27

+3.12%

$29.42M

0IL8.L

Kyntra Bio, Inc.

$7.23

+2.40%

$29.21M

0J4V.L

Heron Therapeutics, Inc.

$1.20

+2.73%

$200.42M

Frequently Asked Questions

What is Atara Biotherapeutics, Inc.'s P/E ratio?

Atara Biotherapeutics, Inc. (0HIY.L) has a trailing twelve-month (TTM) P/E ratio of -1.37. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Atara Biotherapeutics, Inc. pay a dividend?

No, Atara Biotherapeutics, Inc. (0HIY.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Atara Biotherapeutics, Inc.'s market cap?

Atara Biotherapeutics, Inc. (0HIY.L) has a market capitalization of $40.84 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has 0HIY.L performed this year?

Atara Biotherapeutics, Inc. (0HIY.L) has returned -71.99% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.